Leading health brands are moving beyond DTC to build trust through authentic patient engagement, transparency and credible communication.| FleishmanHillard
To remain indispensable, communications agencies must rethink our operating system: how we deliver value, how we scale, and how we measure success.| FleishmanHillard
AI rollouts are stalling. Discover five overlooked risks and how strategic communications can drive real AI adoption and business impact.| FleishmanHillard
FleishmanHillard experts detail how brands can develop plans to continue to confidently contract the right influencers and mitigate risk.| FleishmanHillard
FleishmanHillard’s FH Fusion enables communicators to build AI-powered solutions, combining human insight, data fluency, and industry knowledge.| FleishmanHillard
AI rollout is stalling, not from lack of tech, but from gaps in trust, culture and clarity. Leaders must build the right conditions for adoption to take hold.| FleishmanHillard
In a time of uncertainty and saturation, attention isn’t given. It’s earned through simplicity, creative craft and AI grounded in reality. You could feel it in every conversation. The C-suite under pressure. Creators calling for accountability. Agencies asked to solve faster, smarter, more intentionally. What cut through in the award winners and on the stages […]| FleishmanHillard
On the Ground at Cannes: There’s always a certain kind of energy on the ground at Cannes. But this year, it feels as much like a reckoning with what creativity must become as it is a celebration of a year of groundbreaking work. Yes, we’re honoring culture-shifting campaigns. But more than that, we’re witnessing a […]| FleishmanHillard
Discover the Four Pillars of AI Readiness and how people-first strategies can help leaders drive adoption, build trust, and prepare teams for lasting transformation.| FleishmanHillard
Introducing Sage by FleishmanHillard: a virtual audience platform delivering real-time, synthetic insights to test, co-create, and refine strategy before launch.| FleishmanHillard
As the Food and Drug Administration (FDA) sets global standards in many ways, any disruptions in its operations could create a ripple effect in other regulatory agencies around the world, including the European Medicines Agency (EMA).| FleishmanHillard
Escalation of penalties imposed by Trump administration on China, and the retaliation from Beijing on US imports, will affect nearly every segment of our economy.| FleishmanHillard